Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 35133 | 52 | 42.2 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PDXP | Author keyword | 2 | 67% | 4% | 2 |
| 2 | SITEP PHASE UNIT 1 | Address | 2 | 67% | 4% | 2 |
| 3 | DIOC23 | Author keyword | 1 | 50% | 2% | 1 |
| 4 | KO 143 | Author keyword | 1 | 50% | 2% | 1 |
| 5 | MED CLIN NEPHROL PREVENT SCI | Address | 1 | 50% | 2% | 1 |
| 6 | MOL CELLULAR DEV BIOL BIOL CHEM | Address | 1 | 50% | 2% | 1 |
| 7 | PARTYSMART | Author keyword | 1 | 50% | 2% | 1 |
| 8 | PROJECT GRP CELL SIGNALING | Address | 1 | 50% | 2% | 1 |
| 9 | TRADITIONAL HEALTH CARE SYSTEM | Author keyword | 1 | 50% | 2% | 1 |
| 10 | UNITE GENOM FONCT BIOINFORMAT | Address | 1 | 29% | 4% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PDXP | 2 | 67% | 4% | 2 | Search PDXP | Search PDXP |
| 2 | DIOC23 | 1 | 50% | 2% | 1 | Search DIOC23 | Search DIOC23 |
| 3 | KO 143 | 1 | 50% | 2% | 1 | Search KO+143 | Search KO+143 |
| 4 | PARTYSMART | 1 | 50% | 2% | 1 | Search PARTYSMART | Search PARTYSMART |
| 5 | TRADITIONAL HEALTH CARE SYSTEM | 1 | 50% | 2% | 1 | Search TRADITIONAL+HEALTH+CARE+SYSTEM | Search TRADITIONAL+HEALTH+CARE+SYSTEM |
| 6 | BAY 61 3606 | 0 | 33% | 2% | 1 | Search BAY+61+3606 | Search BAY+61+3606 |
| 7 | IGFR1 | 0 | 33% | 2% | 1 | Search IGFR1 | Search IGFR1 |
| 8 | INDIVIDUALISED TUMOUR RESPONSE TESTING | 0 | 33% | 2% | 1 | Search INDIVIDUALISED+TUMOUR+RESPONSE+TESTING | Search INDIVIDUALISED+TUMOUR+RESPONSE+TESTING |
| 9 | MOLM 13 | 0 | 33% | 2% | 1 | Search MOLM+13 | Search MOLM+13 |
| 10 | DETECTION OF APOPTOSIS | 0 | 25% | 2% | 1 | Search DETECTION+OF+APOPTOSIS | Search DETECTION+OF+APOPTOSIS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ARSENIC TRIOXIDE ATO | 0 | 25% | 2% | 1 |
| 2 | MITOCHONDRIAL ALTERATIONS | 0 | 11% | 4% | 2 |
| 3 | PROTEIN SLP 65 | 0 | 11% | 2% | 1 |
| 4 | B CELL EXPANSION | 0 | 10% | 2% | 1 |
| 5 | CYTOKINE DEPENDENCY | 0 | 10% | 2% | 1 |
| 6 | MITOCHONDRIAL MEDIATED APOPTOSIS | 0 | 10% | 2% | 1 |
| 7 | DATES PHOENIX DACTYLIFERA | 0 | 100% | 2% | 1 |
| 8 | KINASE INHIBITOR P21WAF1 CIP1 MDA6 | 0 | 100% | 2% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Cell death and the well of the organism | 2010 | 0 | 3 | 67% |
| Metabolomic Profiling of Cultured Cancer Cells | 2014 | 0 | 34 | 12% |
| Cell death assays for drug discovery | 2011 | 130 | 121 | 1% |
| Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes | 2009 | 257 | 82 | 2% |
| Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies | 2007 | 39 | 166 | 1% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SITEP PHASE UNIT 1 | 2 | 67% | 3.8% | 2 |
| 2 | MED CLIN NEPHROL PREVENT SCI | 1 | 50% | 1.9% | 1 |
| 3 | MOL CELLULAR DEV BIOL BIOL CHEM | 1 | 50% | 1.9% | 1 |
| 4 | PROJECT GRP CELL SIGNALING | 1 | 50% | 1.9% | 1 |
| 5 | UNITE GENOM FONCT BIOINFORMAT | 1 | 29% | 3.8% | 2 |
| 6 | CLIN INVEST BIOTHER IES CANC CICBT 507 | 0 | 25% | 1.9% | 1 |
| 7 | ENS ANNEX BAMBILI | 0 | 25% | 1.9% | 1 |
| 8 | PEDIAT ONCOL HEMATOL PEDIAT | 0 | 25% | 1.9% | 1 |
| 9 | PHYTOBIOCHEM | 0 | 25% | 1.9% | 1 |
| 10 | UMR8159 | 0 | 25% | 1.9% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000138541 | FLT3//FLT3 ITD//NPM1 |
| 2 | 0.0000097029 | EUPOLYPHAGA SINENSIS WALKER//1 6 METHANO10ANNULENES//INAPT |
| 3 | 0.0000096960 | REVERSINE//MITOTIC CATASTROPHE//WP 631 |
| 4 | 0.0000072548 | SYK//SPLEEN TYROSINE KINASE//R788 |
| 5 | 0.0000070024 | NECROPTOSIS//RIP3//NECROSTATIN 1 |
| 6 | 0.0000069777 | PHOS TAG//SYST LIFE SCI//FUNCT MOL SCI |
| 7 | 0.0000068824 | ARSENIC TRIOXIDE//AS2O3//ARSENIC TRIOXIDE AS2O3 |
| 8 | 0.0000066157 | NIMOTUZUMAB//H R3//CETUXIMAB |
| 9 | 0.0000065320 | LEUKEMIA STEM CELLS//EXPT THER EUT TRANSLAT ONCOL PROGRAM//LEUKEMIC STEM CELL |
| 10 | 0.0000063418 | SAFFLOWER PHOSPHOLIPID//SOYABEAN LECITHIN//SOYBEAN PHOSPHOLIPID |